P672: Switching out of class or to another anti-TNF agent is the most effective strategy in IBD patients with immunogenicity against anti-TNF antibodiesECCO’23 CopenhagenYear: 2023
Authors: AnjieMD, S.(1)*;Hanžel, J.(2);Gecse, K.B.(1);D'Haens, G.R.(1);Brandse, J.F.(3);
(1)Amsterdam UMC, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)University Medical Center Ljubljana, Department of Gastroenterology and Hepatology, Ljubjana, Slovenia;(3)Rijnstate, Department of Gastroenterology and Hepatology, Arnhem, The Netherlands;
P673: The safety of rapid versus standard infliximab infusions in children with inflammatory bowel disease: a multi-centre retrospective cohort studyECCO’23 CopenhagenYear: 2023
Authors: Jagt, J.(1,2)*;Galestin, S.(3);Benninga, M.(1);de Boer, N.(4);de Meij, T.(1);
(1)Amsterdam UMC- location University of Amsterdam, Department of Pediatric Gastroenterology and Nutrition, Amsterdam, The Netherlands;(2)Amsterdam UMC- Vrije Universiteit Amsterdam, Pediatric Gastroenterology- Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands;(3)Amsterdam UMC- location University of Amsterdam, Faculty of Medicine, Amsterdam, The Netherlands;(4)Amsterdam UMC- Vrije Universiteit Amsterdam, Department of Gastroenterology and Hepatology- Amsterdam Gastroenterology and Metabolism Research Institute, Amsterdam, The Netherlands;
P674: Ustekinumab is the preferred biological agent in IBD patients with hidradenitis suppurativa failing anti-TNF therapy : results from a real-life multicenter cohortECCO’23 CopenhagenYear: 2023
Authors: Verstockt., B.(1,2)*;Vieujean, S.(3);Truyens, M.(4,5);Julsgaard, M.(6);Pugliese, D.(7);Aslan, D.(1);Prokopic, M.(8);Lim, S.(9);Viganò, C.(10);Festa, S.(11);Ramos, L.(12);Garciá, M.J.(13);Plaza, R.(14);Noviello, D.(15);Savarino, E.(16);Drobne, D.(17);Imperatore, N.(18);Ribaldone, D.G.(19);Van Dongen, J.(20);Teich, N.(21);Wahed, M.(22);Barberio, B.(23);Goren, I.(24,25);
(1)University Hospitals Leuven, Dpt. Gastroenterology and Hepatology, Leuven, Belgium;(2)KU Leuven, Translational Research in Gastrointestinal Disorders- Department of Chronic Disease & Metabolism, Leuven, Belgium;(3)University Hospital CHU of Liège, Hepato-Gastroenterology and Digestive Oncology, Liège, Belgium;(4)Ghent University Hospital, Department of Gastroenterology, Ghent, Belgium;(5)Ghent University, Department of Internal Medicine and Paediatrics, Ghent, Belgium;(6)Aarhus University Hospital, Gastroenterology, Aarhus, Denmark;(7)Fondazione Policlinico “A Gemelli” IRCSS, Gastroenterology, Roma, Italy;(8)University Hospital Martin- Jessenius Faculty of Medicine- Comenius University, Department of Gastroenterology-, Bratislava, Slovakia;(9)Guy's and St Thomas' NHS Foundation Trust, Gastroenterology, London, United Kingdom;(10)San Gerardo Hospitol- University of Milan Bicocca, Gastroenterology, Monza, Italy;(11)San Filippo Neri Hospital, Gastroenterology, Roma, Italy;(12)Hospital Universitario de Canarias- Spain, Gastroenterology, Gran Canaria, Spain;(13)Hospital Universitario Marqués de Valdecilla- IDIVAL, Gastroenterology, Valdecilla, Spain;(14)Hospital Intana Leonor, Gastroenterology, Madrid, Spain;(15)University of Milan, Department of Pathophysiology and Transplantation-, Milano, Italy;(16)University of Paduo- Azienda Ospedaliera di Padova, Gastroenterology, Padova, Italy;(17)University Medical Centre, Gastroenterology, Ljubiljana, Slovenia;(18)Cardarelli Hospital of Naples, Gastroenterology, Naples, Italy;(19)Università degli Studi di Torino, Gastroenterology, Torino, Italy;(20)AZ Sint Maarten, Gastroenterology, Mechelen, Belgium;(21)Internistische Gemeinschaftspraxis für Verdauungs, Dpt. Gastroenterology, Liepzig, United Kingdom;(22)Chelsea and Westminster NHS Foundation Trust, Gastroenterology, London, United Kingdom;(23)University of Paduo- Azienda Ospedaliera di Padova, Gastroenterology, Padova, Italy;(24)Rabin Medical Center, Division of Gastroenterology, Petah Tikva, Israel;(25)Lerner Research Institute- Cleveland Clinic, Department of inflammation and immunity, Cleveland, United States;
P675: Real world evidence of tofacinitib in ulcerative colitis: short and long-term effectiveness, safety and impact of extraintestinal manifestations and immunomediated diseasesECCO’23 CopenhagenYear: 2023
Authors: Chaparro Sanchez, M.(1)*;Acosta, D.(1);Rodríguez, C.(2);Mesonero, F.(3);Vicuña, M.(2);Barreiro-de Acosta, M.(4);Fernández-Clotet, A.(5);Hernández Martínez, Á.(6); Arroyo, M.(7);Vera, I.(8); Ruiz-Cerulla, A.(9);Sicilia, B.(10);Cabello Tapia, M.J.(11);Muñoz Villafranca, C.(12);Castro-Poceiro, J.(13);Martínez Cadilla, J.(14);Sierra-Ausín, M.(15);Vázquez Morón, J.M.(16);Montil Miguel, E.(17);Bermejo, F.(18);Royo, V.(19);Calafat, M.(20);González-Muñoza, C.(21);Leo Carnerero, E.(22);Manceñido Marcos, N.(23);Torrealba, L.(24); Alonso-Galán, H.(25);Benítez, J.M.(26);Ber Nieto, Y.(27);Diz-Lois Palomares, M.T.(28);García, M.J.(29);Muñoz, J.F.(30);Armesto González, E.M.(31);Calvet, X.(32); Hernández-Camba, A.(33);Madrigal Domínguez, R.E.(34);Menchén, L.(35);Pérez Calle, J.L.(36);Piqueras, M.(37);Gisbert, J.P.(1);
(1)Hospital Universitario de La Princesa- IIS-Princesa- Universidad Autónoma de Madrid UAM- and CIBEREHD, Gastroenterology Unit, Madrid, Spain;(2)Hospital Universitario de Navarra HUN and Instituto de Investigación Sanitaria de Navarra IdiSNA, Gastroenterology Unit, Pamplona, Spain;(3)Hospital Universitario Ramón y Cajal, Gastroenterology Unit, Madrid, Spain;(4)Hospital Clínico Universitario de Santiago de Compostela, Gastroenterology Unit, Santiago de Compostela, Spain;(5)Hospital Clinic of Barcelona- Institut d'Investigacions Biomèdiques August Pi i Sunyer IDIBAPS and CIBERehd, Gastroenterology Unit, Barcelona, Spain;(6)Hospital Universitario Torrecárdenas, Gastroenterology Unit, Almería, Spain;(7)Hospital Clínico Universitario Lozano Blesa- IIS Aragón and CIBEREHD, Gastroenterology Unit, Zaragoza, Spain;(8)Hospital Universitario Puerta de Hierro Majadahonda, Gastroenterology Unit, Madrid, Spain;(9)Hospital Universitario de Bellvitge, Gastroenterology Unit, L´Hospitalet de Llobregat, Spain;(10)Hospital Universitario de Burgos, Gastroenterology Unit, Burgos, Spain;(11)Hospital Universitario Virgen de las Nieves, Gastroenterology Unit, Granada, Spain;(12)Hospital Universitario de Basurto, Gastroenterology Unit, Bilbao, Spain;(13)Hospital Sant Joan Despí-Moisès Broggi, Gastroenterology Unit, Barcelona, Spain;(14)Hospital Álvaro Cunqueiro. Xerencia Xestión Integrada de Vigo- SERGAS. Grupo de Investigación en Patología Digestiva- IIS Galicia Sur. SERGAS-UVIGO, Gastroenterology Unit, Vigo, Spain;(15)Complejo Asistencia Universitario de León, Gastroenterology Unit, León, Spain;(16)Hospital Universitario Juan Ramón Jiménez, Gastroenterology Unit, Huelva, Spain;(17)Hospital Universitario Miguel Servet, Gastroenterology Unit, Zaragoza, Spain;(18)Hospital Universitario de Fuenlabrada and IdiPAZ, Gastroenterology Unit, Madrid, Spain;(19)Hospital Universitari Son Espases, Gastroenterology Unit, Palma de Mallorca, Spain;(20)Hospital Universitari Germans Trias i Pujol and CIBEREHD, Gastroenterology Unit, Badalona, Spain;(21)Hospital de la Santa Creu i Sant Pau, Gastroenterology Unit, Barcelona, Spain;(22)Hospital Universitario Virgen del Rocío, Gastroenterology Unit, Sevilla, Spain;(23)Hospital Universitario Infanta Sofía, Gastroenterology Unit, Madrid, Spain;(24)Hospital Universitario Dr. Josep Trueta, Gastroenterology Unit, Girona, Spain;(25)Hospital Universitario Donostia and Instituto Biodonostia, Gastroenterology Unit, San Sebastián, Spain;(26)Hospital Universitario Reina Sofía and IMIBIC, Gastroenterology Unit, Córdoba, Spain;(27)Hospital San Jorge, Gastroenterology Unit, Huesca, Spain;(28)Complejo Hospitalario Universitario A Coruña, Gastroenterology Unit, A Coruña, Spain;(29)Hospital Universitario de Valdecilla and Instituto de Investigación Sanitaria Valdecilla IDIVAL, Gastroenterology Unit, Santander, Spain;(30)Hospital Universitario de Salamanca, Gastroenterology Unit, Salamanca, Spain;(31)Hospital San Agustín, Gastroenterology Unit, Avilés, Spain;(32)Hospital Universitari Parc Taulí- Universitat Autònoma de Barcelona and CIBERehd, Gastroenterology Unit, Sabadell, Spain;(33)Complejo Hospitalario Universitario Nuestra Señora de Candelaria, Gastroenterology Unit, Santa Cruz de Tenerife, Spain;(34)Hospital Clínico Universitario de Valladolid, Gastroenterology Unit, Valladolid, Spain;(35)Hospital General Universitario Gregorio Marañón, Gastroenterology Unit, Madrid, Spain;(36)Hospital Universitario Fundación Alcorcón, Gastroenterology Unit, Madrid, Spain;(37)Consorci Sanitari de Terrassa, Gastroenterology Unit, Barcelona, Spain;on behalf of To-ReWard study group
P676: Intestinal ultrasound accurately predicts therapy failure in Crohn's disease patients during a biologics-induced remissionECCO’23 CopenhagenYear: 2023
Authors: Albshesh, A.(1)*;Abend, A.(2); Margalit Yehuda, R.(1);Mahajna, H.(1);Ben-Horin, S.(1);Kopylov, U.(1);Carter, D.(1);
(1)Sheba Medical Center and Sackler School of Medicine- Tel-Aviv University, Department of Gastroenterology, Tel Hashomer, Israel;(2)Sheba Medical Center, Department of Internal Medicine F, Tel Hashomer, Israel;
P677: Combination of vedolizumab and exclusive enteral nutrition in patients with moderate to severe Crohn's DiseaseECCO’23 CopenhagenYear: 2023
Authors: Kang, J.(1,2,3);Wang, J.(1,2,3);Lu, Y.(4);Li, J.(1,2,3);Su, J.(1,2,3);Ying, A.(1,2,3);Ren, H.(1,2,3);Zhou, Q.(1,2,3);Wang, Y.(1,2,3);Ding, Y.(1,2,3);An, P.(1,2,3)*;
(1)Renmin Hospital of Wuhan University, Gastroenterology, Wuhan, China;(2)Renmin Hospital of Wuhan University, Hubei Provincial Clinical Research Center for Digestive Disease Minimally Invasive Incision, Wuhan, China;(3)Renmin Hospital of Wuhan University, Key Laboratory of Hubei Province for Digestive System Disease, Wuhan, China;(4)Jingzhou First People's Hospital, Gastroenterology, Jingzhou, China;
P678: Ustekinumab therapy improves the nutritional status in patients with Crohn's Disease. A prospective studyECCO’23 CopenhagenYear: 2023
Authors: BertaniMD, L.(1,2)*;D'Alessandro, C.(1);Fornili, M.(3);Coppini, F.(1);Zanzi, F.(1);Carmisciano, L.(3);Geri, F.(1);Baiano Svizzero, G.(4);Ceccarelli, L.(4);Mumolo, M.G.(4);Baglietto, L.(3);Bellini, M.(1);Costa, F.(4);De Bortoli, N.(1);
(1)University of Pisa, Translational Research and New Technologies in Medicine and Surgery, Pisa, Italy;(2)Tuscany North-West ASL - Pontedera Hospital, General Surgery and Gastroenterology, Pontedera, Italy;(3)University of Pisa, Clinical and Experimental Medicine, Pisa, Italy;(4)Pisa University Hospital, General Surgery and Gastroenterology, Pisa, Italy;
P680: A real-life experience of Crohn's Disease Exclusion Diet use at disease onset and as an add-on therapy in pediatric Crohn's diseaseECCO’23 CopenhagenYear: 2023
Authors: Scarallo, L.(1)*;Fioretti, L.(1);Pochesci, S.(1);Pierattini, V.(2);Banci, E.(2);De Blasi, A.(1);Di Paola, M.(1);Lionetti, P.(1,3);
(1)Meyer Children Hospital, Gastroenterology and Nutrition Unit, Florence, Italy;(2)Meyer Children Hospital, Dietetics Unit, Florence, Italy;(3)University of Florence, Department of NEUROFARBA, Florence, Italy;
P681: Effectiveness and safety of oral Tacrolimus salvage therapy for acute severe ulcerative colitis: a retrospective studyECCO’23 CopenhagenYear: 2023
Authors: Tamir-Degabli, N.(1)*;Cohen, N.A.(2);Hirsch, A.(3);Fishman, S.(2);Ron, Y.(2);Thrum, T.(2);Maharshak, N.(2);
(1)Tel Aviv Sourasky Medical Center- Tel Aviv- Israel, Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel;(2)Tel Aviv Medical Center, Gastroenterology and liver diseases, Tel Aviv, Israel;(3)Tel Aviv Medical Center, Gastroenterology and liver diseases, Tel Avibv, Israel;
P682: Development of anti-ustekinumab antibodies is an independent factor associated to loss of response to ustekinumab therapy in IBD patientsECCO’23 CopenhagenYear: 2023
Authors: Roblin, X.(1)*;Nancey, S.(2);Bastide, L.(3);Veyrard, P.(3);Bischetti, G.(4);Berger, A.E.(5);Barrau, M.(6);Paul, S.(5);
(1)CHU Saint Etienne - Hospital Nord, Department of Gastroenterology and Hepatology- Inserm- CIC1408, Saint Priest en Jarez, France;(2)CHU Lyon Sud, Gastroenterelogy, Lyon, France;(3)CHU Saint Etienne, Gastroenterology, Saint Etiennne, France;(4)CHU Lyon Sud, Gastroneterology, Lyon, France;(5)CHU Saint Etienne, Immunology, Saint Etiennne, France;(6)CHU Saint Etienne, Gastronetrology, Saint Etiennne, France;
P683: Risk factors for fatigue in IBD patients.ECCO’23 CopenhagenYear: 2023
Authors: Sina, M.(1)*;Djegsi, A.(1);Pemaj, X.(1);Telaku, S.(2);Babameto, A.(1);Prifti, S.(1);
(1)University Hospital Center Mother Theresa, Internal Medicine/ Gastroenterology, Tirana, Albania;(2)UBD, Gastroenterology, Pristina, Kosovo;
P687: Durability of recaptured response to ozanimod during the True North open-label extensionECCO’23 CopenhagenYear: 2023
Authors: Dignass, A.(1)*;Regueiro, M.(2);Colombel, J.F.(3);Jain, A.(4);Canavan, J.B.(4);Wu, H.(4);Lawlor, G.(4);Osterman, M.T.(4);Vermeire, S.(5);Rubin, D.T.(6);
(1)Agaplesion Markus Hospital- Goethe University, Medicine, Frankfurt, Germany;(2)Cleveland Clinic- Cleveland, Digestive Disease and Surgery Institute, Cleveland, United States;(3)Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, United States;(4)Bristol Myers Squibb, Clinical Research, Princeton, United States;(5)University of Leuven, Chronic Diseases and Metabolism, Leuven, Belgium;(6)University of Chicago, Gastroenterology, Chicago, United States;
P688: Patient preferences in medication to treat Ulcerative Colitis: a discrete choice experimentECCO’23 CopenhagenYear: 2023
Authors: Straatmijer, T.(1)*;van den Akker-van Marle, E.(2);van der Horst, D.(3);Scherpenzeel, M.(3);Duijvestein, M.(4);van der Meulen, A.(5);
(1)Initiative on Crohn and Colitis, Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)LUMC, Medical decision making, Leiden, The Netherlands;(3)CCNL, Gastroenterology and hepatology, Woerden, The Netherlands;(4)Radboudumc, Gastroenterology and Hepatology, Nijmegen, The Netherlands;(5)LUMC, Gastroenterology and hepatology, Leiden, The Netherlands;
P689: Predictive transcriptional signatures associated to vedolizumab therapy response in patients with ulcerative colitis.ECCO’23 CopenhagenYear: 2023
Authors: Camba Gómez, M.(1)*;Arosa , L.(1);Calviño-Suárez, C.(2);Bastón-Rey, I.(2);Ferreiro-Iglesias, R.(2);Porto, M.(2);Nieto, L.(2);Domínguez-Muñoz, J.E.(2);Barreiro-de Acosta, M.(2);Conde-Aranda, J.(1);
(1)Health Research Institute of Santiago de Compostela IDIS, Molecular and Cellular Gastroenterology, Santiago de Compostela, Spain;(2)University Hospital of Santiago de Compostela, Department of Gastroenterology and Hepatology, Santiago de Compostela, Spain;
P690: Prolonged benefit of filgotinib in patients with Ulcerative Colitis in SELECTIONECCO’23 CopenhagenYear: 2023
Authors: Laharie, D.(1)*;Sturm, A.(2);Kobayashi, T.(3);Matsumoto, T.(4);Oortwijn, A.(5);Jamoul , C.(6);Faes, M.(6);de Haas, A.(7);Vermeire , S.(8);
(1)Hospital Haut-Leveque, Department of Gastroenterology and Hepatology, Pessac, France;(2)DRK Kliniken Berlin Westend, Department of Internal Medicine and Gastroenterology, Berlin, Germany;(3)Center for Advanced IBD Research and Treatment, Kitasato University- Kitasato Institute Hospital, Toyko, Japan;(4)Iwate Medical University, Division of Gastroenterology- Department of Medicine, Morioka, Japan;(5)Galapagos NV, Medical Affairs Department, Leiden, The Netherlands;(6)Galapagos NV, Biostatistics Department, Mechelen, Belgium;(7)Galapagos NV, Clinical Development Department, Leiden, The Netherlands;(8)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;
P691: Disparate care: rates of treat to target among patients with inflammatory bowel diseaseECCO’23 CopenhagenYear: 2023
Authors: Haydek, J.(1);Oonk, A.(1);Cheng, D.(1);Ahmed, W.(1);Click, B.(1);Fennimore, B.(1);Gerich, M.(1);Hou, J.(2);Scott, F.(1)*;
(1)University of Colorado, Crohn's and Colitis Center, Aurora, United States;(2)Baylor College of Medicine, Gastroenterology and Hepatology, Houston, United States;
P693: Italian real-life study evaluating the long-term effectiveness of vedolizumab for the treatment of Inflammatory Bowel Disease- An IG-IBD studyECCO’23 CopenhagenYear: 2023
Authors: Pugliese, D.(1);Privitera, G.(2)*;Armuzzi, A.(3);
(1)Fondazione Policlinico Agostino Gemelli IRCCS, CEMAD- IBD CENTER- Unità Operativa Complessa di Medicina Interna e Gastroenterologia- Dipartimento di Scienze Mediche e Chirurgiche, Rome, Italy;(2)Università Cattolica del Sacro Cuore, Dipartimento di Medicina e Chirurgia Traslazionale, Roma, Italy;(3)IRCCS Humanitas Research Hospital, IBD Center, Rozzano, Italy;IG-IBD LIVE Studygroup
